Shenzhen BGI Genomics Co., Ltd. (hereinafter referred to as the "Company") announces that the third lock-up period of the first grant of the second employee stock ownership plan (hereinafter referred to as the "Plan") will expire on June 1, 2026. Given that the Company's performance in 2025 did not meet the performance assessment targets for the unlocking of the shares, the unlocking conditions for this portion of the Plan have not been fulfilled.
1. Progress of the Plan and Expiration of the Lock-up Period
(1) Progress of the Plan
-
Review of the Plan The Company held the 13th meeting of the third board of directors and the 14th meeting of the third supervisory board on November 18, 2022, and convened the fifth extraordinary general meeting of shareholders on December 6, 2022, to review and approve the proposal regarding the "Draft of the Second Employee Stock Ownership Plan of Shenzhen BGI Genomics Co., Ltd." and related proposals, thereby agreeing to implement the second employee stock ownership plan. Specific details can be found in the announcements disclosed by the Company on November 19, 2022, and December 6, 2022, on the Giant Tide Information Network (http://www.cninfo.com.cn).
-
Source and Holding of Shares According to the relevant provisions of the "Second Employee Stock Ownership Plan of Shenzhen BGI Genomics Co., Ltd.", the shares for this Plan are sourced from the Company's repurchased A-share common stock, totaling 4,000,141 shares, accounting for 0.9664% of the Company's total share capital of 4,139,143,250 shares as of the announcement date of the draft plan. The total actual subscription amount for this Plan is 115,324,066 yuan, with an actual subscription of 11,532,406.66 shares. Among these, the shares subscribed by the initial holders (i.e., the first grant portion) amount to 57,664,066 shares, accounting for 50.0018% of the Plan, while the reserved shares amount to 57,660,000 shares, accounting for 49.9982%. On February 2, 2023, the Company received the "Securities Transfer Registration Confirmation" issued by the Shenzhen Branch of China Securities Depository and Clearing Co., Ltd., confirming that the 4,000,141 shares held in the Company's repurchase account were transferred to the "Shenzhen BGI Genomics Co., Ltd. - Second Employee Stock Ownership Plan" account on February 1, 2023, accounting for 0.9664% of the Company's total share capital at that time, with a transfer price of 28.83 yuan/share. The number of shares subscribed by each holder and the actual transferred shares are consistent with the numbers approved at the fifth extraordinary general meeting of shareholders in 2022. Specific details can be found in the announcement titled "Completion of Non-transaction Transfer of the Second Employee Stock Ownership Plan" disclosed by the Company on February 2, 2023 (Announcement No.: 2023-014).
(2) Explanation of the Expiration of the Lock-up Period
- Explanation of the Expiration of the First Lock-up Period The first lock-up period of the first grant of the Plan expired on June 1, 2024, with the unlocked equity portion accounting for 30% of the total equity of the first grant portion of the Plan. Specific details can be found in the announcement titled "Notice of Expiration of the First Lock-up Period of the First Grant Portion of the Second Employee Stock Ownership Plan" disclosed by the Company on May 29, 2024 (Announcement No.: 2024-040).